SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : TATRADER GIZZARD STUDY--Stocks 12.00 or Less.....
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Findit who wrote (57707)2/26/2007 5:59:02 PM
From: lexi2004  Read Replies (1) of 59879
 
THLD doesn't seem to be a one-drug company, so you might be getting a bargain if you are willing to hold after initial selling:

Threshold Pharmaceuticals, Inc., a development stage company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of benign prostatic hyperplasia and cancer. Its product candidates include TH-070, a Phase II and III product, which is used for the treatment of symptomatic benign prostatic hyperplasia; Glufosfamide, a Phase II and III product, for the treatment of cancer; 2-deoxyglucose, or 2DG, a Phase I trial product, for the treatment of solid tumors. The company was founded by George F. Tidmarsh. Threshold Pharmaceuticals was incorporated in 2001 and is headquartered in Redwood City, California.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News